The Antibody Society has partnered with numerous conference organizers, including KNect365, Cambridge Healthtech Institute, Hanson Wade and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
March 2019
Festival of Biologics San Diego
March 3-5, 2019, San Diego, CA
The Festival of Biologics San Diego was born out of our successful European event, the Festival Of Biologics Basel, which consists of 5 world leading events: The European Antibody Congress, the World Immunotherapy Congress, Clinical Trials 2018, The World Biosimilar Congress and HPAPI World Congress. Having run very successfully in Basel, Switzerland for the past three years, and across other European countries for the past 13 years, it was time to bring our event across the pond to the US, where biologics research and development is fast growing and innovative.
With high level, global speakers from big pharma, biotech, academia and industry, the Festival of Biologics San Diego will address the strategic and commercial aspects of discovering, developing, and bringing new biologics to patients. We bring you two days packed full of top level science, data and case studies, workshops, roundtables and networking opportunities. With 200+ speakers, 80 sponsors and exhibitors and hundreds of companies in attendance, this is not an event to be missed.
Society members save 15%! Contact us at membership@antibodysociety.org for the discount registration code.
World ADC London
March 4-6, 2019, London
World ADC London is Europe’s leading antibody-drug conjugate conference. Across three days, this comprehensive three streamed program will cover every element of ADCs from discovery, development, manufacturing and clinical.
Attend World ADC London to validate novel ADC targets, improve understanding of mechanisms driving toxicity in clinical development and robustly scale up process development to support commercialization. 320 drug developers across 140+ active organizations will unite at this industry focused conference to foster new connections, further develop business relationships and meet with current partners.
You can download the program here and register here.
Society members save 20%! Contact us at membership@antibodysociety.org for the discount registration code.
ICI-IO Combinations Summit
March 19-21, Boston, MA
Advancing ICI-containing IO-combination therapies is central to getting the full therapeutic benefit out of ICIs. Selecting the right combination partners and strategies are essential to the making the correct decision. The 5th annual ICI-IO Combinations Summit will focus on how the response rate to checkpoint combinations can be enhanced to impact every stage of the cancer immunity cycle, as well as shed light on the specific challenges that come with combining IO therapies with ICIs. Through interactive workshops, panel discussions and roundtables, this is a great opportunity to gain practical implementable insight into IO combo development strategy.
View the full event guide for more information.
Society members save 10% on registration! Contact us at membership@antibodysociety.org for the discount registration code.
Phar-East
March 19-20, 2019, Singapore
Returning in 2019 after a successful 2018 debut, Phar-East will once again bring together experts from Asian pharma & biotechs, big pharma, regulators, payers, technology innovators and more to share their expertise and chart Asia’s path forward.
On 19 – 20 March, the 2-day conference will be exploring 6 of the most exciting areas of Asian pharma:
Immunotherapy
Market access
Regulatory affairs
Pharma 4.0
Clinical Trials
Biotech Investment
Pre-conference workshops are available on 18 March.
Join over 800 industry leaders now by registering here.
Society members save 15% on the registration fee! Contact us at membership@antibodysociety.org for the code.
Innate Killer Summit 2019
March 19-21, 2019, San Diego, CA
The 4th Innate Killer Summit is an annual industry meeting providing a platform for leaders in the natural killer (NK) cell field to network, interact and learn at the only end-to-end meeting that fosters the transformation of leading science to commercial therapies. As the understanding of NK cells improves year on year, the challenges of producing effective NK cell therapies are top priorities to overcome. Manufacturing processes need to be streamlined and regulatory landscapes better understood. It is imperative that we can come together to exchange ideas to overcome the hurdles of getting the best immunotherapies to patients in need.
Society members save 15% on the registration fee! Contact us at membership@antibodysociety.org for the code.
April 2019
PEGS: The Essential Protein Engineering Summit
April 8-12, 2019, Seaport World Trade Center, Boston, MA
PEGS Boston 2019 will host more than 400 lectures, panels, tutorials and round-table discussions, along with 150+ exhibitors, and 300 research posters on display in the exhibit hall. The speaker lineup includes industry leading experts, visionaries, and influencers from top pharma, biotech, academia, and government institutions.
View the speaker lineup, program agenda and registration options online at www.PEGSummit.com
Society members save 20% on the registration fee! Contact us at membership@antibodysociety.org for the code.
May 2019
May 11-15, 2019, University of Genoa Scuola Politecnica, Italy
The 4th Adaptive Immune Response Repertoire Community Meeting will be held May 11-15, 2019 at the University of Genoa Scuola Politecnica, Italy. The theme of this meeting, “Bridging the Gaps” addresses technological gaps between the amounts of accumulated data and our ability to process them, and the need for more involvement of stakeholder communities (industry, clinicians, patient communities) for uptake of the standards developed by the AIRR Community.
We have confirmed two outstanding Keynote speakers – Dr. Sai Reddy from ETH Zurich and Dr. Antonio Lanzavecchia from IRB Bellinzona. Two planned panel discussions will include representatives from other institutions and companies that work with AIRR-seq data. In addition, two “challenge” sessions are planned to address the above-mentioned gaps. Two pre-meeting workshops will be available to teach the basics of immunology, and of AIRR-seq data analysis for beginners. Two poster sessions and two tool and software demos sessions are also planned.
More information and the draft agenda can be found here.
Registration for this meeting is now open – click here to register!
Antibodies & Complement
May 20-25, 2019, Girona, Spain
This 2nd conference on Antibodies & Complement will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts. Some of the critical topics to be covered include:
- antibody & complement (novel) functions
- human antibody repertoires
- complement structure and subcellular localization
- novel technologies
- complement and antibody therapies
After the success of the first edition, this second conference on Antibodies & Complement should again be a forum for leaders in the field and new investigators coming from academia, industry and research institutes to discuss where the field is going and what challenges lie ahead.
Attention students and post-doctoral fellows!
Travel grants (€500-€650) will be awarded to selected students and postdocs attendees. Selection will be performed by the conference organizers and session chairs.
The Antibody Society is offering up to 7 travel grants to both recognize the research activities of promising students / postdoctoral fellows and provide educational opportunities to them. In order to be considered for this competition, you must be a student or postdoc member of The Antibody Society. If you are not already a member, you may register here for a free student or postdoc membership.
Requirements:
- Submit an abstract to the conference organizers by April 4, 2019
- Request financial support including a support letter from your mentor
- Register for free at The Antibody Society
June 2019
7th Antibody Industrial Symposium
June 24-25, Tours, France
The 7th Antibody Industrial Symposium (AIS2019) will be held on June 24-25, 2019 in Tours, France. The AIS provides an ideal congress to keep up to date with the latest innovation and progress in the exciting field of therapeutic antibodies.
We are thrilled to share with you that this year edition will focus on Harnessing the Immune System with therapeutic antibodies, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University. Indeed, immune responses can be modulated with mAbs and may be harnessed to enhance antibody functions. The AIS2019 will cover the multifaceted mechanisms underlying antibody-mediated immune responses.
Join more than 300 experts expected for this new edition, working in the field of mAbs and related services and technologies and hear the latest advances in academia and how industry is pushing forward innovation for the development of new therapies. Register HERE.
Submit an Abstract to give a Pitch or Present a Poster: Deadline March 29, 2019
Check the guideline online HERE.
Society members save 20% on the registration fee! Contact us at membership@antibodysociety.org for the code.
Antibody Engineering & Therapeutics Europe
June 11-13, 2019
Postillion Hotel Amsterdam, the Netherlands
Join us for The Antibody Society’s 2nd annual Antibody Engineering & Therapeutics Europe meeting, where you will connect with industry and academic scientists and executives from Europe and around the world focused on antibody and protein therapeutic discovery and development.
Keynote speakers Jane Osbourn, Ph.D., (Vice President R&D and Site Leader of Medimmune) will discuss antibody therapeutic developments, pipeline and progress at Medimmune and Hans Clevers, M.D., Ph.D., (Group Leader, Hubrecht Institute for Developmental Biology and Stem Cell Research and Professor of Molecular Genetics, University Medical Center Utrecht and Utrecht University) will discuss Lgr5 stem cell-based organoids and their applications in cancer research. In addition, the meeting features sessions on Turning Antibody Leads into Drugs, Recent Advances in Immuno-Oncology Approaches, Bioinformatics and Repertoires in Antibody Discovery and Development, Antibody Therapeutics for Autoimmune and Neurodegenerative Diseases, Clinical Developments in Antibody Therapeutics, and New Antibody Formats and Effector Functions.
The preliminary agenda can be downloaded here.
Society members save 15% on the registration fee when using the code Antibody15!
NEW FOR 2019!
Antibody Engineering & Therapeutics Europe Student/Postdoc Poster Competition
To recognize the research activities of promising student/postdoc attendees of the Antibody Engineering & Therapeutics conference, The Antibody Society is sponsoring a student/postdoc poster competition. Two student/postdoc winners will be selected to receive:
1) Complimentary registration to attend the conference and pre-conference sessions;
2) Support for travel expenses (up to $400 for domestic or $800 for international flights, 2 nights at a hotel, ground transportation).
In order to be considered for this poster competition, you must be a student or postdoc member of The Antibody Society. If you are not already a member, you may register here for a free student or postdoc membership. KNect365 is managing the poster submission process. Please use the form located here to submit your poster, and be sure to check the box on the poster submission form indicating that you want your abstract to be considered for the poster competition.
Deadline for submission: April 24, 2019
Winners will be notified by May 1, 2019
The Antibody Society’s Symposium at the Federation of Clinical Immunology Societies (FOCIS) annual meeting
June 18, 2019
Boston Marriott Copley Place, Boston, MA
“Developing Therapeutic Antibodies for Successful Entry into the Clinic”
Although many antibody-engineering labs are focused on translational work, most antibody-based therapeutics developed in academia, and many developed by small companies, either do not make it into clinical study or do not proceed past Phase 1. Few are ultimately licensed by large pharmaceutical firms because many antibodies developed in academic labs are not associated with sufficiently robust characteristics to allow successful commercial development.
In addition, academic labs and small biotech often encounter difficulty in securing funding for the development of clinical-grade material and subsequent clinical trials. Taking interesting laboratory discoveries to the next step is further hindered by a lack of knowledge about what venture capital (VC)/biotech/pharma companies are interested in, who to talk to, and how to make a deal. What makes a new antibody-based therapeutic sufficiently novel to attract interest?
This symposium is designed to bring together scientists and entrepreneurs who will share their experiences with successfully tackling these and other issues that block the clinical development of many antibody-based therapeutics.
For more information and to register for the meeting, click here.
Program (8am-noon)
8.00-8.35am Greg Adams (Sesen Bio)
- Introduction to The Antibody Society and the purpose of this symposium
- Why does this session matter to academic/biotech scientists who want to develop clinical agents?
8.35-9.10am Yingda Yu (Adimab)
- Designing and screening for the properties that decrease the risk of failure during clinical development of an antibody
- Screening for function, stability and specificity
9.10-9.45am Wayne Marasco (MGH/Harvard)
- Screening antibodies for clinically relevant function
- Investigator-initiated Phase 1 clinical studies
9.45-10.15am Coffee break
10.15-10.50am Jim Larrick (Panorama Research Institute, Velocity Pharmaceutical Development)
- Supporting clinical research with grant funding
- Taking a preclinical lead to the clinic
10.50-11.25am Patrick Baeuerle (MPM Capital)
- Bringing a new class of antibodies to the clinic
- Building a biotech
- Selling to pharma
- View from the VC world
11.25-12.00 Abbie Celniker (3rd Rock Ventures)
- Formation and development of VC-backed companies
- What does a VC look for: 1) in a platform or 2) in a scientific team?
September 2019
SAVE THE DATE: Nanobody Symposium
September 5 – 6, 2019, University of Bonn, Germany
This symposium is will bring together scientists from different disciplines who do (or would like to) develop, modify, and apply nanobodies for basic research, diagnostics, and therapy. It will thus be a forum to exchange experience and knowledge across different fields, and hear about the latest research in both the generation and application of nanobodies. Attendees will hear 18 outstanding scientists give invited lectures at the symposium, and there will be ample time for further presentations and posters from selected participants. Workshops to foster exchange of practical information are planned.
Please visit our preliminary website for further information (including the speaker list). A more detailed website will go live in January 2019.
In the meantime, please note the following details for your calendar:
Venue: University of Bonn, Venusberg campus, Biomedical Center (Building 13), Lecture Hall
Date and Time: September 5 – 6, 2019
Program: Invited and selected presentations, workshops, and poster session (evening of September 5th)
Contact: Please contact us using this email address: nanobodies2019@event.uni-bonn.de
Registration: Registration will open in January 2019
